版本:
中国

BRIEF-Adaptimmune Therapeutics names Helen Tayton-Martin as chief business officer

March 15 Adaptimmune Therapeutics Plc:

* Adaptimmune Therapeutics- appointment of co-founder, Helen Tayton-Martin to role of chief business officer, William (Bill) Bertrand, Jr., J.D., as COO Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐